Sally C. Pipes
Commentary
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Commentary
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Commentary
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Commentary
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Health Care
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Commentary
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
Commentary
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Commentary
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Commentary
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...
